AdvancedAdvT (LON:ADVT) Trading Down 0.3% - Time to Sell?

Key Points

• AdvancedAdvT Limited's share price fell by 0.3% to GBX 179.40 ($2.39) on Friday, with trading volume down 72% from average levels.
• Shore Capital has issued a "buy" rating and a price target of GBX 240, with the stock holding a consensus rating of "Buy" among analysts.
• The company, which focuses on business combinations, has a market cap of £244.75 million and a PE ratio of 22.43.

AdvancedAdvT Limited (LON:ADVT - Get Free Report)'s share price fell 0.3% during trading on Friday . The stock traded as low as GBX 176.25 ($2.35) and last traded at GBX 179.40 ($2.39). 61,868 shares were traded during trading, a decline of 72% from the average session volume of 219,173 shares. The stock had previously closed at GBX 180 ($2.40).

Analysts Set New Price Targets

Separately, Shore Capital restated a "buy" rating and set a GBX 240 price target on shares of AdvancedAdvT in a research report on Thursday, October 2nd. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, AdvancedAdvT has a consensus rating of "Buy" and an average price target of GBX 240.

AdvancedAdvT Trading Down 0.3%

The company has a market cap of £244.75 million, a PE ratio of 22.43 and a beta of 0.52. The stock has a 50 day moving average price of GBX 188.62 and a 200 day moving average price of GBX 175.32.

About AdvancedAdvT

AdvancedAdvT Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Marwyn Acquisition Company I Limited and changed its name to AdvancedAdvT Limited in March 2021.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.